Published by
@ShahidNShah
@ShahidNShah
February 21 to February 23, 2023
Embassy Suites by Hilton Boston at Logan Airport, 207 Porter Street, Boston, Massachusetts, 02128, United States
With numerous next-generation conjugate companies recently receiving their INDs to enter the clinic including Avidity Biosciences and Dyne Therapeutics and many more following closely in their footsteps, conjugate drugs comprising of novel payloads and targeting formats are being thrust centre stage within the bioconjugate world.
The 2nd Next-Generation Conjugate Summit is your only platform dedicated to showcasing out-of-the-box technologies and approaches to design conjugates with novel modes of action. Furthermore, learn how to overcome key translational challenges including model selection and regulatory guidance, as well as addressing important downstream manufacturing and scale-up challenges.
Read on next-gen-conjugates.com
Continue reading at next-gen-conjugates.com
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Foundation, Inc. All Rights Reserved.
Built on Nov 21, 2024 at 6:20am